Skip to content

Establishment of an Artificial Larynx After Total Laryngectomy

Establishment of an Artificial Larynx After Total Laryngectomy

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01474005
Acronym
LA
Enrollment
5
Registered
2011-11-17
Start date
2011-10-31
Completion date
2013-10-31
Last updated
2012-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carcinomatous Disease

Keywords

laryngectomy, artificial larynx, breathing, swallowing, upper airway

Brief summary

This study aims to evaluate the effectiveness of an artificial larynx on the restoration of laryngeal functions, mainly breathing and swallowing.

Interventions

DEVICEPROTIP MEDICAL ( Artificial larynx prosthesis)

establishment of an artificial larynx prosthesis

Sponsors

University Hospital, Strasbourg, France
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Anyone over 18 years, male or female, with a carcinomatous disease of the upper airways requiring a total laryngectomy

Exclusion criteria

* Less than 18 years * Contraindications to general anesthesia * Any situation considered by the physician operator as an exclusion * Pregnant women * Lactating women * Subglottic or basi-lingual tumor extension more than 1 cm * Prior radiotherapy * Severe coagulation disorders

Design outcomes

Primary

MeasureTime frameDescription
Evaluation of the restoration of respiratory functionsone year4 items will be used: * 0: no dyspnea * 1: moderate dyspnea * 2: significant dyspnea * 3: major dyspnea
Evaluation of the restoration of the ability to swallow by nasofibroscopyone year3 items will be used: * 1: no aspiration * 2: moderate aspiration * 3: massive aspiration

Countries

France

Contacts

Primary ContactChristian DEBRY, PU-PH
christian.debry@chru-strasbourg.fr03.88.12.76.45

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026